Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food (Q37420530)

From Wikidata

Jump to navigation Jump to search

scientific article published on 11 March 2016

Language	Label	Description	Also known as
English	Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food	scientific article published on 11 March 2016

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Extended-Release Once-Daily Formulation of Tofacitinib: Evaluation of Pharmacokinetics Compared With Immediate-Release Tofacitinib and Impact of Food (English)

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

author name string

Manisha Lamba

1

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Rong Wang

2

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Tracey Fletcher

3

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Christine Alvey

4

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Joseph Kushner

5

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Thomas C Stock

6

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

publication date

11 March 2016

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

56

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

11

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

1362-1371

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Dosing frequency and medication adherence in chronic disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Inhibition of JAK kinases in patients with rheumatoid arthritis: scientific rationale and clinical outcomes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Anti-inflammatory activity and neutrophil reductions mediated by the JAK1/JAK3 inhibitor, CP-690,550, in rat adjuvant-induced arthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Co-administration of the JAK inhibitor CP-690,550 and methotrexate is well tolerated in patients with rheumatoid arthritis without need for dose adjustment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Oral osmotically driven systems: 30 years of development and clinical use

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Influence of food intake on plasma oxprenolol concentrations following oral administration of conventional and Oros preparations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Influence of food on the bioavailability of metoprolol from an OROS system; a study in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

23 August 2017

Exposure-response modeling using latent variables for the efficacy of a JAK3 inhibitor administered to rheumatoid arthritis patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

14 September 2017

The nifedipine gastrointestinal therapeutic system (GITS). Evaluation of pharmaceutical, pharmacokinetic and pharmacological properties

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

28 September 2017

Extrudable core system: development of a single-layer osmotic controlled-release tablet

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

2 September 2018

The specificity of JAK3 kinase inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5113768

2 September 2018

Effect of food on the pharmacokinetics of osmotic controlled-release methylphenidate HCl in healthy subjects

1 reference

https://api.crossref.org/works/10.1002%2FJCPH.734

21 January 2018

Identifiers

10.1002/JCPH.734

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

20 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37420530&oldid=2114203566"